Clinical management of thalassemia. Decreasing iron stores during intensive chelation therapy

Ann N Y Acad Sci. 1980:344:405-8. doi: 10.1111/j.1749-6632.1980.tb33679.x.
No abstract available

Publication types

  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Ascorbic Acid / therapeutic use
  • Blood Transfusion
  • Child
  • Deferoxamine / administration & dosage
  • Deferoxamine / therapeutic use*
  • Erythrocyte Transfusion
  • Humans
  • Iron / metabolism*
  • Male
  • Thalassemia / metabolism
  • Thalassemia / therapy*

Substances

  • Iron
  • Deferoxamine
  • Ascorbic Acid